Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF for Knee Osteoarthritis
NCT03940950Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2019
- Primary completion
- May 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous adipose-derived stromal vascular fraction in osteoarthritis (OA), sponsored by Mayo Clinic. Started Jul 2019; status: completed.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03940950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940950.